» Articles » PMID: 10754001

Linkage of Familial Moyamoya Disease (spontaneous Occlusion of the Circle of Willis) to Chromosome 17q25

Overview
Journal Stroke
Date 2001 Feb 7
PMID 10754001
Citations 68
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Purpose: Moyamoya disease is a cerebrovascular disease of unknown cause that mainly affects Japanese children. The incidence of familial occurrence accounts for 9% of cases. The characteristic lesions of moyamoya disease are occasionally seen in neurofibromatosis type 1, of which the causative gene (NF1) has been assigned to chromosome 17q11.2.

Methods: To determine whether a gene related to moyamoya disease is located on chromosome 17, we conducted microsatellite linkage analyses on 24 families containing 56 patients with moyamoya disease. Leukocyte DNA extracted from the family members was subjected to polymerase chain reaction for a total of 22 microsatellite markers on chromosome 17. The amplified polymerase chain reaction fragments were analyzed with GeneScan on an automated sequencer.

Results: Two-point linkage analysis gave a maximum log(10) odds (LOD) score of 3.11 at the recombination fraction of 0.00 for the marker at locus D17S939. The affected pedigree member method also showed a significantly low P value (<1. 0x10(-5)) for the 5 adjacent markers at 17q25. Multipoint linkage analysis also indicated that the disease gene is contained within the 9-cM region of D17S785 to D17S836, with a maximum LOD score of 4. 58.

Conclusions: A gene for familial moyamoya disease is located on chromosome 17q25.

Citing Articles

Low hemoglobin is associated with postoperative cerebral infarction in moyamoya disease: development of a predictive model based on low hemoglobin.

Wu H, Wang T, Li F, Bao Y, Lu B, Li L Front Neurol. 2025; 15():1489430.

PMID: 39839859 PMC: 11746082. DOI: 10.3389/fneur.2024.1489430.


Insights into the regulatory role of epigenetics in moyamoya disease: Current advances and future prospectives.

Xu S, Chen T, Yu J, Wan L, Zhang J, Chen J Mol Ther Nucleic Acids. 2024; 35(3):102281.

PMID: 39188306 PMC: 11345382. DOI: 10.1016/j.omtn.2024.102281.


Novel analysis of functional relationship linking moyamoya disease to moyamoya syndrome.

Cao L, Yang W, Duan X, Shao Y, Zhang Z, Wang C Heliyon. 2024; 10(14):e34600.

PMID: 39149038 PMC: 11325278. DOI: 10.1016/j.heliyon.2024.e34600.


RNF213 in moyamoya disease: Genotype-phenotype association and the underlying mechanism.

Fang J, Yang X, Ni J Chin Med J (Engl). 2024; 137(21):2552-2560.

PMID: 38243713 PMC: 11557053. DOI: 10.1097/CM9.0000000000002985.


Propofol versus Desflurane in Moyamoya Disease Patients-A Pilot Study.

Ankolekar R, Kaur K, Jangra K, Aggarwal A, Panda N, Bhagat H Asian J Neurosurg. 2024; 18(4):826-830.

PMID: 38161613 PMC: 10756770. DOI: 10.1055/s-0043-1775588.